AARP Mississippi Shows Impact of Skyrocketing Drug Prices on Mississippians with New Data, Infographic
AARP Mississippi today released new state data and an infographic illustrating the impact of high prescription drug prices for Mississippi residents, specifically those living with cancer, prediabetes or diabetes, and heart disease. AARP unveiled the infographic at the National Academy for State Health Policy (NASHP) annual conference as part of AARP’s nationwide Stop Rx Greed campaign to lower drug prices for all Americans.
For decades, big pharmaceutical companies have raised drug prices with impunity. Here in Alabama, the average annual cost of brand name prescription drug treatment increased 58% between 2012 and 2017...
AARP Texas thanks Senator John Cornyn for voting this week in favor of a key bill designed to rein in drug prices. Passage by the Senate Finance Committee of the Prescription Drug Pricing Reduction Act of 2019 is a crucial first step leading up to full Senate action.
AARP is backing two pieces of legislation aimed at curbing drug prices, by providing those who prescribe them unbiased information on pharmaceuticals and mandating more transparency on how manufacturers set the costs of prescription meds.
AARP Iowa relies on its Grass Roots Election and Advocacy Team (GREAT) volunteers to be the boots on the ground across the state, telling lawmakers about legislation and policy concerns.
Search AARP States
Sign Up & Stay Connected